Search Within

GME, Medicine

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (146)
  2. Journal Article (143)
  3. Research Letter (8)
  4. Review (4)
  5. Editorial (3)
Groups
  1. Graduate Medical Education (304)
  2. Human Oncology and Pathogenesis Program (304)
  3. GSK Faculty (300)
  4. Department of Medicine (290)
  5. Hematology-Oncology Fellows (247)
  6. Solid Tumor Oncology Division (202)

More Groups

People
  1. Michael Berger (67)
  2. Nikolaus Schultz (53)
  3. Marc Ladanyi (48)
  4. Marcel Van Den Brink (40)
  5. David Solit (35)
  6. Santosha Vardhana (34)

More People

Years
  1. 2025 (21)
  2. 2024 (75)
  3. 2023 (81)
  4. 2022 (53)
  5. 2021 (17)
  6. 2020 (12)

More Years

Publications
  1. Journal of Clinical Oncology (68)
  2. Blood (31)
  3. Clinical Cancer Research (20)
  4. Cancer Research (17)
  5. Annals of Oncology (12)
  6. JCO Precision Oncology (10)

More Publications

Publishers
  1. American Society of Clinical Oncology (78)
  2. American Association for Cancer Research (45)
  3. American Society of Hematology (35)
  4. Elsevier Inc. (29)
  5. Nature Publishing Group (24)
  6. Oxford University Press (24)

More Publishers

Results (304)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A comprehensive comparison of early-onset and average-onset colorectal cancers
    Journal Article

    Cercek, A.; Chatila, W. K.; Yaeger, R.; Walch, H.; Dos Santos Fernandes, G.; Krishnan, A.; Palmaira, L.; Maio, A.; Kemel, Y.; Srinivasan, P.; more...
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small cell lung cancer
    Meeting Abstract

    Jee, J.; Lebow, E. S.; Murciano-Goroff, Y. R.; Jayakumaran, G.; Shen, R.; Brannon, A. R.; Benayed, R.; Namakydoust, A.; Offin, M.; Paik, P. K.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Frequency of minimal residual disease as measured by ctDNA in mismatch repair deficient tumors following curative resection
    Meeting Abstract

    Lumish, M. A.; Jayakumaran, G.; Fox, M.; Sabwa, S.; Cercek, A.; Stadler, Z. K.; Ku, G. Y.; Segal, N. H.; Won, E.; Maron, S. B.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Large cell neuroendocrine carcinoma of the urothelial tract (LNEC): The MSKCC experience
    Meeting Abstract

    Guercio, B. J.; Gandhi, J.; Teo, M. Y.; Lattanzi, M.; Funt, S. A.; Aggen, D. H.; Chen, Y. B.; Fine, S.; Pietzak, E. J.; Bochner, B. H.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of adult lymphoma-associated hemophagocytic lymphohistiocytosis (HLH)
    Meeting Abstract

    Lee, C. Y.; Wills, B.; Vardhana, S. A.; Moskowitz, A. J.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Sustained minimal residual disease negativity in multiple myeloma is impacted positively by stool butyrate and healthier plant forward diets
    Meeting Abstract

    Shah, U.; Derkach, A.; Adintori, P.; Cross, J.; Maclachlan, K.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Tan, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Phase II trial of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Shah, G.; Schòˆder, H.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Ryu, S.; Sohail, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway
    Journal Article

    Smith, A. E.; Ferraro, E.; Safonov, A.; Morales, C. B.; Lahuerta, E. J. A.; Li, Q.; Kulick, A.; Ross, D.; Solit, D. B.; de Stanchina, E.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Clonal hematopoiesis is associated with risk of severe COVID-19
    Journal Article

    Bolton, K. L.; Koh, Y.; Foote, M. B.; Im, H.; Jee, J.; Sun, C. H.; Safonov, A.; Ptashkin, R.; Moon, J. H.; Lee, J. Y.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Prospects for epigenetic targeted therapies of bone and soft-tissue sarcomas
    Review

    Wang, J.; Elkrief, A.; Guo, W.; Shukla, N.; Gounder, M.; Ladanyi, M.
    Sarcoma (2021)

    Fulltext@MSK | Save